SMAD7, HIF-1α gene and HIF-1α protein may be jointly involved in tumor development and prognosis (act as oncogenic factors), while SEC13, GHRL, and lncRNA GHRLOS may act as tumor suppressor factors and thus could be considered as novel therapeutic targets for gastric cancer. This evidence concerns the gene GHRL and gastric cancer.